Non-alcoholic Fatty Liver Disease Affect Efficacy of Immune Checkpoint Inhibitors for Patients with Hepatocellular Carcinoma: Manifestations and Mechanisms

Non-alcoholic Fatty Liver Disease Affect Efficacy of Immune Checkpoint Inhibitors for Patients with Hepatocellular Carcinoma: Manifestations and Mechanisms

The number of patients with the combination of non-alcoholic fatty liver disease (NAFLD) and hepatocellular carcinoma (HCC) is gradually increasing. In recent years, the immunotherapy has become a new effective way to treat unresectable HCC. The clinical research revealed that the NAFLD could affect...

Full description

Bibliographic Details
Main Authors: YUAN Ye, PENG Hui, TIAN De'an
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2022-11-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
non-alcoholic fatty liver disease
hepatocellular carcinoma
immune checkpoint blockade
efficacy
Online Access:http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.22.0562

Internet

http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.22.0562

Similar Items